Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 323,182 $ 117,373,818 $ (121,204,000) $ (3,507,000)
Balance at beginning, shares at Dec. 31, 2020 323,181,243      
Adjustment for adoption of ASU 2020-06   (60,000) 30,000 (30,000)
Common stock issued on conversion of notes payable $ 2,200 41,800 44,000
Common stock issued on conversion of notes payable, shares 2,200,000      
Value of warrants issued with convertible notes 30,000 30,000
Fair value of options and warrants issued as compensation 13,000 13,000
Issuance of common stock for cash $ 3,000 42,000 45,000
Issuance of common stock for cash, shares 3,000,000      
Net loss (371,000) (371,000)
Ending balance, value at Mar. 31, 2021 $ 328,382 117,440,618 (121,545,000) (3,776,000)
Balance at ending, shares at Mar. 31, 2021 328,381,243      
Beginning balance, value at Dec. 31, 2021 $ 355,301 118,065,699 (122,594,000) (4,173,000)
Balance at beginning, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 367 5,633 6,000
Common stock issued on conversion of notes payable, shares 366,666      
Common stock issued on exercise of warrants $ 825 24,175 25,000
Common stock issued on exercise of warrants, shares 825,000      
Fair value of warrants issued as compensation 24,000 24,000
Net loss (301,000) (301,000)
Ending balance, value at Mar. 31, 2022 $ 356,493 $ 118,119,507 $ (122,895,000) $ (4,419,000)
Balance at ending, shares at Mar. 31, 2022 356,491,888